Ciprofibrate in the treatment combined hyperlipiproteinaemia. Result a total of 633 patients from 23 centres in the Czech Republic;Ciprofibrat v lecbe kombinovane hyperlipoproteinemie. Vysledky u vice nez 600 nemocnych z 23 center v CR

Vnitrni Lekarstvi

Volumn 46, Issue 3, 2000, Pages 157-160

  Ceska, R ^a   Kvasnicka, T ^a   Haas, T ^a   Soska, V ^a   Vaverkova, H ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Atherogenic index; Ciprofibrate; Combined hyperlipoproteinaemia; Hypercholesterolaemia; Hypertriglyceridaemi a

Indexed keywords

CHOLESTEROL; CIPROFIBRATE; HIGH DENSITY LIPOPROTEIN; ANTILIPEMIC AGENT; CLOFIBRIC ACID; DRUG DERIVATIVE;

ARTICLE; CHOLESTEROL BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HYPERLIPOPROTEINEMIA; MAJOR CLINICAL STUDY; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; CLINICAL TRIAL; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY;

ANTILIPEMIC AGENTS; CLOFIBRIC ACID; FEMALE; HUMANS; HYPERLIPOPROTEINEMIAS; MALE; MIDDLE AGED;

EID: 0034099507     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)